Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Morgan

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumabAnne M Schultheis, Georg Lurje, Katrin E Rhodes, et al.
Journal of the American Heart Association|September 29, 2023
Association of Atherosclerotic Cardiovascular Disease, Hypertension, Diabetes, and Hyperlipidemia With Gulf War Illness Among Gulf War VeteransSarah T Ahmed, Ruosha Li, Peter Richardson, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2002
Phase I pharmacodynamic study of time and sequence dependency of hydroxyurea in combination with gemcitabine: a California Cancer Consortium TrialYun Yen, Warren Chow, Lucille Leong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortiaAgustin A Garcia, Hal Hirte, Gini Fleming, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine ChemotherapyNicola R Hardwick, Paul Frankel, Christopher Ruel, et al.
Neuroendocrinology|July 2, 2025
Smoking Adversely Affects Survival of Metastatic Lung Carcinoid Patients: Analysis of a Large International Audit and Prognostic Models for Metastasis-Free Survival and Overall SurvivalAmy Clarke, Aimee Cunningham, Alejandro Garcia-Alvarez, et al.
Journal of the American Geriatrics Society|July 23, 2013
Caregiver outcomes of partners in dementia care: effect of a care coordination program for veterans with dementia and their family members and friendsDavid M Bass, Katherine S Judge, A Lynn Snow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapyGeorge Somlo, Paul Frankel, Warren Chow, et al.
Gynecologic Oncology|July 16, 2015
Consensus in controversy: The modified Delphi method applied to Gynecologic Oncology practiceDavid E Cohn, Laura J Havrilesky, Kathryn Osann, et al.
Molecular Cancer Therapeutics|October 17, 2014
Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancerWei Wen, Wei Liang, Jun Wu, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumabAnne M Schultheis, Georg Lurje, Katrin E Rhodes, et al.
Journal of the American Heart Association|September 29, 2023
Association of Atherosclerotic Cardiovascular Disease, Hypertension, Diabetes, and Hyperlipidemia With Gulf War Illness Among Gulf War VeteransSarah T Ahmed, Ruosha Li, Peter Richardson, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2002
Phase I pharmacodynamic study of time and sequence dependency of hydroxyurea in combination with gemcitabine: a California Cancer Consortium TrialYun Yen, Warren Chow, Lucille Leong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 2008
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortiaAgustin A Garcia, Hal Hirte, Gini Fleming, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 6, 2018
p53-Reactive T Cells Are Associated with Clinical Benefit in Patients with Platinum-Resistant Epithelial Ovarian Cancer After Treatment with a p53 Vaccine and Gemcitabine ChemotherapyNicola R Hardwick, Paul Frankel, Christopher Ruel, et al.
Neuroendocrinology|July 2, 2025
Smoking Adversely Affects Survival of Metastatic Lung Carcinoid Patients: Analysis of a Large International Audit and Prognostic Models for Metastasis-Free Survival and Overall SurvivalAmy Clarke, Aimee Cunningham, Alejandro Garcia-Alvarez, et al.
Journal of the American Geriatrics Society|July 23, 2013
Caregiver outcomes of partners in dementia care: effect of a care coordination program for veterans with dementia and their family members and friendsDavid M Bass, Katherine S Judge, A Lynn Snow, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapyGeorge Somlo, Paul Frankel, Warren Chow, et al.
Gynecologic Oncology|July 16, 2015
Consensus in controversy: The modified Delphi method applied to Gynecologic Oncology practiceDavid E Cohn, Laura J Havrilesky, Kathryn Osann, et al.
Molecular Cancer Therapeutics|October 17, 2014
Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancerWei Wen, Wei Liang, Jun Wu, et al.
Pageof 16